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Abstract
Background
The emergency department (ED) is mentioned specifically in the Swiss HIV testing recom-
mendations as a site at which patients can benefit from expanded HIV testing to optimise
early HIV diagnosis. At our centre, where local HIV seroprevalence is 0.2–0.4%, 1% of all
patients presenting to the ED are tested for HIV. Barriers to HIV testing, from the patient and
doctor perspective, and patient acceptability of rapid HIV testing were examined in this
study.
Methods
Between October 2014 and May 2015, 100 discrete patient-doctor encounter pairs under-
took a survey in the ED of Lausanne University Hospital, Switzerland. Patients completed a
questionnaire on HIV risk factors and were offered free rapid HIV testing (INSTI™). For
every patient included, the treating doctor was asked if HIV testing had 1) been indicated
according to the national testing recommendations, 2) mentioned, and 3) offered during the
consultation.
Results
Of 100 patients, 30 had indications for HIV testing through risk factors or a suggestive pre-
senting complaint (PC). Fifty patients accepted rapid testing; no test was reactive. Of 50
patients declining testing, 82% considered themselves not at risk or had recently tested neg-
ative and 16% wished to focus on their PC. ED doctors identified 20 patients with testing
indications, mentioned testing to nine and offered testing to six. The main reason for doctors
not mentioning or not offering testing was the wish to focus on the PC.
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Discussion
Patients and doctors at our ED share the testing barrier of wishing to focus on the PC. Rapid
HIV testing offered in parallel to the patient-doctor consultation increased the testing rate
from 6% (offered by doctors) to 50%. Introducing this service would enable testing of
patients not offered tests by their doctors and reduce missed opportunities for early HIV
diagnosis.
Background
Early diagnosis and treatment of HIV infection optimises the benefit of antiretroviral therapy
and prevents onward transmission. In Switzerland, while 50.2% of patients presenting with
HIV infection are diagnosed promptly, the remainder are diagnosed late, with CD4 counts
below 350 cells/mm3 or an AIDS-defining event [1, 2].
HIV testing strategies can be characterised as 1) non-targeted, whereby individuals seeking
healthcare are offered an HIV test regardless of their symptoms and signs and regardless of
their risk-factor profile for HIV acquisition, or 2) targeted, whereby the offer of HIV testing is
restricted to individuals presenting symptoms and signs suggestive of HIV-associated indica-
tor conditions (ICs), those with conditions in whom HIV infection should be excluded, such
as pregnancy or prior to commencing immunosuppressant therapy, or those considered at
risk of HIV acquisition. Diagnostic testing refers to the specific situation in which testing is
performed to confirm rather than exclude HIV infection and can be considered as a sub-type
of targeted testing. In addition, patient consent to testing can be opt-out, where testing is per-
formed unless the patient explicitly declines, or opt-in, where testing is offered and then per-
formed if the patient accepts.
In Switzerland, the Federal Office of Public Health (FOPH) recommends targeted and diag-
nostic HIV testing and highlights the emergency department (ED) as a service in which testing
should occur [3]. The FOPH recommendations, first published in 2007 and updated in 2010,
2013 and 2015 [3–6], comprehensively list five main groups of HIV testing indications: symp-
toms and signs of acute HIV infection; conditions pathognomonic of AIDS; conditions in
which HIV infection occurs in>0.5% of cases (ICs); conditions in which HIV infection should
be excluded; and populations in whom the risk of HIV acquisition is high (men who have sex
with men (MSM), injecting drug users (IDUs), individuals from countries with high HIV sero-
prevalence, notably sub-Saharan Africa, and those with sexual partners from a high-risk
group). The recommendations refer to physician-initiated counselling and testing (PICT) in
which the health care provider must initiate the offer of HIV testing when it is indicated; con-
sent to testing is opt-in.
Despite the FOPH recommendations, the HIV testing rate in the ED at our centre is around
1% of all patients seen [7]. Indeed, even in EDs in the United States (US), where the Centers
for Disease Control and Prevention (CDC) recommend non-targeted, opt-out testing [8], phy-
sician-initiated testing has resulted in low (<1%) HIV testing rates [9]. Several barriers to HIV
testing in the US ED setting have been reported. Patient barriers include the belief that testing
is unnecessary, through lack of risk or a recent negative test [10], the wish to focus on the rea-
son for presenting to the ED [10], and concerns regarding confidentiality [10, 11], while doctor
barriers involve competing priorities [12], confidentiality [11], time [13, 14] and space [13],
concerns regarding follow-up care [13, 14], and the perception that HIV testing is not part of
emergency care provision [13]. Many of these studies were published in settings where the
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main method of HIV testing was a laboratory-based test. More recently, the implementation
of rapid HIV testing on oral fluid samples has been reported to increase testing rates [15]. In
the United Kingdom (UK), HIV testing on oral fluid samples was successfully implemented in
settings in which the UK national HIV testing guidelines recommend non-targeted testing
(where local diagnosed HIV prevalence is greater than 2 /1000 persons) by providing supple-
mentary personal to initiate testing [16]. Another means of increasing HIV testing rates in the
ED is to add-on HIV testing to existing blood draws [17].
In Switzerland, the health care system, patient population and HIV testing recommenda-
tions differ from those of the US and the UK, and HIV testing barriers may also differ. The pri-
mary aim of this study was to examine patient and doctor barriers to HIV testing in the ED, in
a setting in which universal (non-targeted) testing is not recommended. Two secondary aims
were to examine 1) doctor capacity to identify patients with HIV testing indications and 2)
patient acceptance of rapid HIV testing.
Methods
Ethics statement
The study was approved by the Ethical Committee on Human Research of the Canton of
Vaud, Switzerland (protocol number 95/14). Participants gave written consent prior to both
study inclusion and rapid HIV testing.
Study setting and participants
The study took place between 1 October 2014 and 19 May 2015 in the ED of Lausanne Univer-
sity Hospital (LUH), Lausanne, Switzerland. LUH ED provides around 40,000 consultations
per year [18] and HIV seroprevalence in the local population is 0.2–0.4% [19, 20]. In this
setting, HIV testing is performed on venous blood using a laboratory-based fourth generation
screening assay which identifies anti-HIV-1/2 antibodies (IgG and IgM) and the p24 antigen
(Cobas Elecsys HIV combi PT, Roche Diagnostics, Switzerland). Reactive samples undergo a
neutralisation assay for the p24 antigen (Cobas Elecsys HIV Ag Confirmatory Test, Roche
Diagnostics), a line immunoassay (INNO-LIA™ HIV I/II Score, Innogenetics NV) and a
plasma viral load determination (Cobas AmpliPrep/Cobas TaqMan HIV-1, version 2.0, Roche
Diagnostics) before they are released as positive for HIV. A result is available in 120 minutes
(during working hours) or the following day. At the time of this study, rapid HIV testing was
not part of standard practice at LUH ED.
The study participants were 1) ED patients aged 18–75 years old and 2) ED doctors treating
included patients. Exclusion criteria (patients) were clinical instability, transfer from another
hospital / prison, admission >12 hours prior to inclusion, known positive HIV status and
inability to provide informed consent. Doctors had no exclusion criteria but participation was
restricted to a maximum of four questionnaires per shift to avoid behaviour change (Haw-
thorne effect).
Study design
The study was prospective and cross-sectional with a convenience sample of 100 discrete
patient-doctor pairs who undertook a face-to-face survey using a paper questionnaire (S1
Text. Questionnaire). Patient inclusion, patient and doctor surveys, questionnaire response
documentation and rapid testing of patients were performed by two final-year medical stu-
dents (NDR and ND, referred to as the study investigators) as part of a Masters thesis. Such a
thesis requires 400 hours of work and for this reason the convenience sample was limited to
Identifying patient-doctor barriers to HIV testing in the emergency department
PLOS ONE | https://doi.org/10.1371/journal.pone.0180389 July 21, 2017 3 / 13
100 patient-doctor pairs to ensure time to conduct the study, analyse the results and produce a
manuscript whilst continuing to fulfil their medical study commitments.
The study investigators identified eligible patients using the live ED computer system and
approached patients after their initial patient-doctor consultation, having confirmed with the
relevant ED doctor that this was convenient (Fig 1).
The study investigators conducted the study over 36 shifts. During a single shift, they sur-
veyed between zero and eight patient-doctor pairs, depending on patient eligibility and
Fig 1. Flow chart showing the sequence of patient inclusion, study patient participation (questionnaire and rapid HIV testing) and
doctor participation (questionnaire). Boxes with rounded corners indicate numbers; those with squared corners indicate processes.
https://doi.org/10.1371/journal.pone.0180389.g001
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availability. Patients consenting to participate completed a questionnaire (see below) and were
offered a free rapid HIV test. The ED doctor of each included patient completed the doctor
questionnaire within 24 hours of the clinical episode, the period from the initial to the final
patient-doctor consultation (Fig 1). Prior to the study, ED doctors attended training seminars
covering the latest FOPH testing recommendations published at the time of the study [21], the
practice of testing and the study protocol, and were given a pocket-sized card summarising the
recommendations (S2 Text. Recommendations).
The patient questionnaire had three sections and took approximately 15 minutes to com-
plete. Section 1 covered demographic details and the reason for presentation (presenting
complaint, PC), HIV testing history, and HIV risk factors derived from the FOPH testing rec-
ommendations [21]. In Section 2, patients were asked if they would have liked to have been
offered HIV testing and, where applicable, the reasons they did not mention HIV themselves.
In Section 3, patients were offered rapid HIV testing using fingertip blood (24 INSTI™ HIV-1/
HIV-2 Rapid Antibody Test, BioLytical Laboratories, Richmond, BC, Canada) and invited to
give reasons for accepting or declining testing from a list of response options. Patient surveys
occurred between 08:00H and 16:00H to ensure access to a duty infectious diseases physician
in the event of a reactive test.
The doctor questionnaire covered demographic details and postgraduate experience then
asked doctors 1) if HIV testing had been indicated according to the FOPH testing recommen-
dations, 2) if they had mentioned HIV and 3) if they had offered testing, providing reasons in
each case from a list of options.
The questionnaire formats were analogous to those of questionnaires previously employed
locally [22, 23] and nationally (www.lovelife.ch, a public information site). A pilot study was
conducted among patient-doctor pairs at LUH ED throughout October 2014 to validate the
questionnaires for content and to confirm practical feasibility of rapid testing.
Data management and statistical analysis
Data from the paper questionnaires were entered independently into two separate databases
by each of the two investigators. The databases were then merged and discrepancies were
resolved by checking the original questionnaire to ensure data accuracy [24].
For analysis, patients were grouped by HIV risk according to FOPH testing recommenda-
tions as described in the Background. Group A patients gave a PC suggestive of primary HIV
infection; group B patients presented HIV risk factors and/or condomless sex with sexual
partner(s) with risk factors; group C patients reported condomless sex during the preceding
six months but no other risk factors; group D patients reported no risk factors. Rates of HIV
testing offered, accepted and performed were calculated for ED doctors and the study
investigators.
Data are presented as mean ± standard deviation (SD), median and inter-quartile range
(IQR) and as percentages. Proportions were compared using the Chi-squared test, or Fisher’s
exact test when appropriate. Statistical analyses were conducted using Microsoft Excel 2010
(Microsoft Corporation, Redmond, WA, USA).
Results
Patients
Between 11 November 2014 and 19 May 2015, 135 eligible patients were identified of whom
100 (75%) were available to participate (Fig 1). The main obstacle to including patients was
not being able to confirm with the relevant ED doctor that this was convenient. Of patients
ineligible (at least one patient per shift), the main reason was age being over 75 years, followed
Identifying patient-doctor barriers to HIV testing in the emergency department
PLOS ONE | https://doi.org/10.1371/journal.pone.0180389 July 21, 2017 5 / 13
by inability to provide informed consent (acute psychiatric episode, intoxication and/or inabil-
ity to speak French) and clinical instability.
As 100 patient-doctor pairs were included, participant numbers and percentages are pre-
sented interchangeably unless subgroups are described (Table 1).
Most patients (83%) had not considered HIV testing during their ED consultation and gave
not being at risk and wishing to focus on their PC as the main reasons (Table 2).
The 17 patients who would have liked to have been tested gave the reasons of wishing to
focus on the PC and not being at risk as the main reasons for not mentioning HIV to their ED
doctor (Table 2).
Fifty patients accepted rapid testing offered by the study investigators, through wishing to
confirm negative HIV status (84%), to benefit from free testing (10%), and concern of being at
risk (6%) (single response allowed); no test was reactive. Patients declining rapid testing
Table 1. Patient characteristics, in total and by HIV risk group.
All patients
(n = 100)
Group A/B
(n = 30)
Group C
(n = 48)
Group D
(n = 22)
P value5
Age (years), mean (SD) 39.9 (13) 37.7 (12) 40.8 (13) 41 (15) 0.9
Nationality, n (%)
Switzerland 56 (56) 11 (37) 27 (56) 18 (82) 0.17
Europe 28 (28) 10 (33) 17 (35) 1 (4.6)
Other 16 (16) 9 (30) 4 (8.3) 3 (14)
Male sex, n (%) 65 (65) 18 (60) 34 (71) 13 (60) 0.9
Low-acuity patients1, n (%) 88 (88) 24 (80) 44 (92) 20 (91) 0.31
Discharged, n (%) 77 (77) 21 (70) 40 (83) 16 (73) 0.88
Risk factors2, n (%)
MSM 2 (2) 2 (6.7) - - NA
Bisexual 3 (3) 3 (10) - -
IDUs (current or former) 2 (2) 2 (6.7) - -
Sub-Saharan African origin 6 (6) 6 (20) - -
CS with high risk partner 18 (18) 18 (60) - -
Followed by family doctor, n (%) 80 (80) 25 (83) 38 (79) 17 (77) 0.9
CS in past six months3, n (%)
Yes (1 sexual partner) 68 (68) 20 (67) 48 (100) NA -
With stable partner only 62 (91) 16 (80) 46 (96) 0.36
HIV testing history4, n (%)
1 previous test 66 (66) 22 (73) 36 (75) 8 (36) 0.03
Tested within past 12 months 26 (39) 11 (50) 13 (36) 2 (25) -
Attitude to HIV testing at ED visit
Wishing to discuss HIV with doctor 17 (17) 6 (20) 8 (17) 3 (14) 0.9
Accepting rapid HIV testing 50 (50) 14 (47) 26 (54) 10 (46) 0.9
1Low-acuity patients had minor injuries or complaints not requiring regular monitoring of vital signs and/or neurological status.
2Risk factors were those defined in the Swiss Federal Office of Public Health HIV testing recommendations (5). As some patients had HIV risk factors
themselves and reported condomless sex (CS) with sexual partners with risk factors, the total number of patients exceeds the number of patients in group
A/B;
3Patients reporting CS solely with a stable partner are presented as a percentage of patients reporting CS;
4Patients tested within the past 12 months are presented as a percentage of those tested;
5Group A/B is used as the reference when comparing patient risk groups unless stated otherwise.
Abbreviations: SD, standard deviation; ED, emergency department; MSM, Men who have sex with men; IDUs, injecting drug users; CS, condomless sex.
https://doi.org/10.1371/journal.pone.0180389.t001
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believed themselves not at risk (56%), had recently tested negative (26%), preferred to focus on
the PC (16%) or feared needles (one patient, 2%) (single response allowed).
Doctors
All ED doctors (total 33) treating the 100 included patients agreed to participate. Participating
ED doctors were predominantly junior grade (93%) with median postgraduate experience
three years (IQR 1:3.5). The median number of questionnaires completed by a single ED doc-
tor was two (IQR 2:4; range 2–9), and the median number completed within a single shift was
one (IQR 1:2; range 1–4). Questionnaires were completed by each doctor during the same
shift in which the patient-doctor consultation had taken place in all but five cases (in which the
questionnaire was completed within 24 hours of the consultation). Doctors identified FOPH
testing indications in 20 patients, including two identified erroneously (‘vaginal candidiasis’
and ‘intuition’). Sensitivity for identifying patients with testing indications (groups A/B) was
30% and specificity was 87%.
By the end of the clinical episode, doctors mentioned HIV to nine patients and offered
testing to six (Fig 2).
The most common reason for not mentioning HIV or offering testing was wishing to focus
/ remain relevant to the PC (Table 3).
There was no difference in testing behaviour associated with the number of times a doctor
participated or with particular time points during the study (data not shown). The patients
offered HIV testing were seen by six different doctors.
Each study investigator performed rapid HIV testing on 50% of the patients they ques-
tioned. There was no difference in the demography of patients recruited by each investigator
and no difference in HIV testing rates with time (P>0.9).
Discussion
This is the first study exploring patient and doctor barriers to HIV testing in the Swiss ED
setting. Both patients and doctors wished to focus on the PC over discussing HIV. Whilst
Table 2. Patient reasons for not mentioning HIV during the consultation with their emergency depart-
ment doctor.
Reasons for not
mentioning HIV
Patients who did not wish to
discuss HIV with the ED doctor, n
(%)
(n = 83)
Patients who wished to discuss HIV
but did not bring up the subject, n (%)
(n = 17)
Wish to focus on PC 51 (62) 10 (59)
Patient not at risk 72 (87) 8 (47)
Forgot NA 6 (35)
Recent negative test 4 (4.8) NA
Feel embarrassed or
afraid
22 (27) 1 (5.9)
Do not want to bother
the doctor
NA 1 (5.9)
Concerned about
confidentiality
NA 0 (0)
As multiple responses were allowed, the total number for each column is greater than the number of
participants in each group.
Abbreviations: ED, emergency department; PC, presenting complaint; NA, not applicable.
NA refers to the reason not being listed as an option in the specific questionnaire section.
https://doi.org/10.1371/journal.pone.0180389.t002
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medically valid, this shared wish was also a shared barrier to testing, as 75% of doctors who
identified testing indications failed to offer testing. A further doctor barrier was the low (30%)
sensitivity for identifying patients with testing indications, despite training seminars and
pocket information cards. These findings are concerning if doctors are expected to initiate test-
ing in line with FOPH recommendations.
Not being at risk was cited by both patients and doctors. The patients in this study were
mainly Swiss or European. Importantly, there were no significant differences in age, sex,
nationality (European or non-European) or access to primary health care between the different
HIV risk groups. There are therefore no demographic markers arising from this patient sample
which could be applied to the general ED population to enable easy identification of at-risk
patients. To do this, it is necessary to take a detailed and specific sexual history, particularly as
self-perceived, or self-reported, risk may not equate to true risk [1, 25, 26]. Indeed, among ED
patients at one US urban centre, patients declining HIV testing had an almost three-fold
higher rate of undiagnosed HIV infection [27]. As sexual history taking may be time-
Fig 2. Flow chart showing the identification of Federal Office of Public Health (FOPH) indications for HIV testing, mention of HIV
and offer of HIV testing by emergency department (ED) doctors, presented according to patient HIV risk group. 1Group A: patients
with a reason for presenting suggestive of primary HIV infection; Group B: patients presenting HIV risk factors and/or reporting condomless
sex with sexual partner(s) with risk factors; Group C: patients reporting condomless sex but no other risk factors; Group D: patients reporting
no risk factors.
https://doi.org/10.1371/journal.pone.0180389.g002
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consuming, this step is often omitted by doctors seeing patients with unrelated complaints in
settings with less time pressure than an ED [28, 29].
Rapid testing offered in parallel to the patient-doctor consultation circumvents the barrier
of incompletely assessing HIV risk. Further, by initiating a dialogue, it is clear to the patient
which test is being offered. In the current study, rapid testing was accepted by 50% of patients,
including patients who did not wish initially to be tested. It is noteworthy that none of the
patients who initially wished to be tested during the patient-doctor consultation mentioned
HIV if the subject was not broached by the ED doctor. Conversely, the mention of HIV and
offer of testing by the study investigators in parallel to the ED consultation resulted in 41% of
the 83 patients who did not wish to be tested initially, agreeing to rapid HIV testing. These
observations suggest that testing rates can be optimised by actively mentioning HIV and offer-
ing testing rather than waiting for the patient to ask. Another argument for an active dialogue
is the previous observation at our centre that some patients believe erroneously that having a
blood test means they have been tested for HIV, even if HIV was not mentioned by their doc-
tor [23, 30]. As recent HIV testing was one of the main reasons for declining testing in the cur-
rent study, it is possible that an erroneous belief of having been tested previously could lead to
reticence towards ‘repeat’ testing and delayed HIV diagnosis in positive patients.
Although this study was not powered to compare HIV testing rates between doctors and
the study investigators, the latter offering non-targeted testing as part of the study protocol
and the former conducting targeted testing when this was considered to be indicated, the dif-
ference in testing rates occurring during the patient-doctor consultation and through rapid
testing was marked: 6% versus 50%. Rather than informing ED doctors about HIV testing rec-
ommendations, testing could be offered by non-medical health care personnel working in par-
allel to the medical consultation. Indeed, the 2013 and 2015 FOPH recommendations state
explicitly that the testing directive applies not only to doctors but to medical personnel in col-
laboration with doctors [5, 6]. A potentially more cost-effective approach would be to employ
electronic devices, such as tablet computers [31]. These could be issued to patients as they wait
to be seen, asking questions on risk factors for HIV acquisition, similar to the paper question-
naire in this study but without the need for additional personnel. In the context of HIV risk
Table 3. Doctor reasons for not mentioning HIV and not offering testing to patients when indicated
according to the Federal Office of Public Health (FOPH) testing recommendations.
Reasons for not mentioning HIV or not
offering HIV testing
Doctors who did not
mention HIV, n (%)
(n = 91)
Doctors who did not offer
testing, n(%)
(n = 15)
Not relevant to PC 65 (71) 7 (47)
Wish to focus on PC 40 (44) 3 (20)
Patient not at risk 27 (30) NA
HIV testing not indicated 24 (26) NA
Have more urgent care to provide 20 (22) 0 (0)
Forgot 0 (0) 4 (27)
Proposed testing elsewhere NA 4 (27)
Recent negative test NA 3 (20)
Concerned about confidentiality 0 (0) 0 (0)
As multiple responses were allowed, the total number for each column is greater than the number of
participants in each group.
Abbreviations: ED, emergency department; PC, presenting complaint; NA, not applicable.
NA refers to the reason not being listed as an option in the specific questionnaire section.
https://doi.org/10.1371/journal.pone.0180389.t003
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factor screening, the use of tablets has been reported to be well-accepted by patients, and may
provide more accurate data on high risk behaviour than face-to-face surveys [32, 33].
This study has limitations. First, only clinically stable patients aged 18 to 75 years old were
eligible, so most patients were recruited from the low-acuity section. Our findings therefore
cannot be applied to the whole ED population, although older patients (over 75 years old) are
more frequently clinically unstable [34]. In this way, offering HIV testing to low-acuity
patients in parallel to the patient-doctor consultation does not replace routine, non-targeted
testing and could potentially miss undiagnosed HIV in more unwell patients. Second, patients
might have been grouped incorrectly by risk factor. Patients in group A had one or a combina-
tion of fever, flu-like symptoms or lymphadenopathy, because only the main PC was docu-
mented in the questionnaire, whereas the FOPH recommendations propose testing in patients
with at least two of these symptoms. However, as only six patients belonged to group A, reclas-
sification would have a marginal effect. Group B patients not engaging in high-risk behaviour
since their last negative HIV test would have met criteria for grouping as C or D. However,
whilst this might overestimate the number of patients ‘missed’ for testing, it does not alter the
number identified as having testing indications but not offered testing. Third, needing to con-
firm that it was convenient for the ED doctor to conduct the patient survey slowed patient
inclusion and, as the surveys were conducted during working hours, the patient sample stud-
ied may not be representative. However, the latter bias is limited as patients were eligible if
admitted within 12 hours. Moreover, whilst selection bias might influence patient testing
uptake, it would not influence doctor testing approach. Finally, although rapid testing uptake
might increase through being free, only five patients gave cost as their main motivation.
In conclusion, patients and doctors share the barrier to HIV testing of wishing to focus on
the PC. The offer of rapid HIV testing in parallel to the patient-doctor consultation was accept-
able to patients, performed without complication and resulted in a testing rate of 50%. Offer-
ing non-targeted rapid HIV testing in our ED would enable testing of patients who may
present HIV risk factors but would not otherwise be tested during their visit. An analysis of
the cost-effectiveness of introducing such a measure using electronic tablets, against new HIV
diagnoses likely to be made, is currently underway.
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